|
Originally published In Press as doi:10.1074/jbc.M102510200 on June 14, 2001
J. Biol. Chem., Vol. 276, Issue 34, 32101-32108, August 24, 2001
An in Vitro Reducing System for the Enzymic
Conversion of Cobalamin to Adenosylcobalamin*
Maris V.
Fonseca and
Jorge C.
Escalante-Semerena§
From the Department of Bacteriology, University of Wisconsin,
Madison, Wisconsin 53706
Received for publication, March 20, 2001, and in revised form, June 11, 2001
 |
ABSTRACT |
Homogeneous ferredoxin
(flavodoxin):NADP+ reductase and flavodoxin A
proteins served as electron donors for the reduction of co(III)rrinoids
to co(I)rrinoids in vitro. The resulting co(I)rrinoids served as substrates for the ATP:co(I)rrinoid
adenosyltransferase (CobA) enzyme of Salmonella enterica
serovar Typhimurium LT2 and were converted to their respective
adenosylated derivatives. The reaction products were isolated by
reverse phase high performance liquid chromatography, and their
identities were confirmed by UV-visible spectroscopy, mass
spectrometry, and in vivo biological activity assays.
Adenosylcobalamin generated by this system supported the activity of
1,2-propanediol dehydratase as effectively as authentic
adenosylcobalamin. This is the first report of a protein system that
can be coupled to the adenosyltransferase CobA enzyme for the
conversion of co(III)rrinoids to their adenosylated derivatives.
 |
INTRODUCTION |
Adenosylcobalamin
(AdoCbl)1 is a structurally
complex coenzyme (Fig. 1). Its
biosynthesis has been studied in a number of procaryotes (1-5), where
aerobic and anaerobic pathways for its generation have been identified
(3, 5, 6). Conversion of biologically inactive forms of Cbl, such as
CNCbl (vitamin B12) to AdoCbl must occur before it can
function as a coenzyme. This conversion requires reduction of the
cobalt atom in the corrin ring to its Co(I) state before it can
be covalently attached to the 5'-deoxyadenosyl moiety from ATP to yield
AdoCbl. The process was thought to require three enzymic activities
(7): a cob(III)alamin reductase (EC 1.6.99.8), a
cob(II)alamin reductase (EC 1.6.99.9), and an ATP:co(I)rrinoid adenosyltransferase (EC 2.5.1.17) (CobA in Salmonella
enterica). The adenosyltransferase enzyme has been studied in
several organisms (7-13). Recently, the three-dimensional structure of
the CobA enzyme of S. enterica was solved in its apoenzyme
form, complexed with MgATP, and complexed with HOCbl and MgATP (14),
revealing a new mode for corrinoid binding that is substantially
different from that of Cbl-dependent enzymes (15-18).
The reducing system involved in the corrinoid adenosylation pathway is
not well understood in any of the organisms in which Cbl biosynthesis
has been studied. The corrinoid reducing activities described to date
in procaryotes were reported to require pyridine nucleotides and free
flavin nucleotides for activity (7, 8, 19), and thus activity has been
attributed to easily dissociable flavoproteins. However, it was
recently shown that co(III)rrinoid reduction can be chemically achieved
by dihydroflavin nucleotides in the absence of any enzymes (20). The
identity of the enzyme catalyzing the reduction of Co(II) to Co(I)
remained unknown. Although a cob(II)yrinic acid
a,c-diamide reductase was isolated from
Pseudomonas denitrificans, neither the enzyme nor the gene responsible for this activity was identified (19).
At present, the only well documented cob(II)alamin reduction reaction
is the one required for reductive activation of the E. coli
methionine synthase enzyme (MetH). The MetH enzyme becomes inactive
once every 2,000 turnovers when cob(I)alamin oxidizes to cob(II)alamin
(21). The electrons for the reduction of cob(II)alamin to cob(I)alamin
in MetH are provided by reduced flavodoxin (FldA) (22-24). It has been
demonstrated that very specific interactions between FldA and MetH are
required for cob(II)alamin reduction to occur (21, 24, 25). The data
presented herein show that the NADP+:ferredoxin
(flavodoxin) reductase (Fpr) and FldA proteins can reduce
co(III)rrinoids to co(I)rrinoids, the substrates of the CobA. The
results from spectroscopic analyses and enzymic and biological activity
assays are reported to show that the product of the in vitro
adenosylation reaction was the adenosylated derivative of the corrinoid
substrate used. It is proposed that the Fpr and FldA proteins are part
of the corrinoid adenosylation pathway in S. enterica.
 |
EXPERIMENTAL PROCEDURES |
Reagents
Unless otherwise stated, all reagents including
(CN)2Cbi, HOCbl, CNCbl, and AdoCbl were obtained from Sigma.
Protein Purification
Purification of E. coli Fpr
Step 1: Mass Culturing of the Overexpressing Strain and
Generation of Cell-free Extracts--
Fpr protein was overproduced
from strain JE4937 (E. coli C-1a/pEE1010, a gift from
Elisabeth Haggård-Ljungquist, Stockholm University, Stockholm, Sweden)
grown overnight at 37 °C on Luria Bertani broth containing 100 µg/ml of ampicillin and 30 mM glucose. The cells were
harvested by centrifugation at 10,000 × g for 10 min
using a Sorvall GSA rotor (DuPont Instruments, Wilmington, DE).
Approximately 20 g of cells were resuspended in 50 mM
Tris-Cl buffer pH 7.5 at 4 °C (buffer A) containing 16 µg/ml of
protein inhibitor phenylmethanesulfonyl fluoride. The cell suspension was broken by sonication using a Sonic Dismembrator (model 550; Fisher)
for 13 min (large tip, setting of 6, 50% duty). Cell-free extracts
were generated by centrifugation at 40,000 × g using a
KOMP Spin rotor (model KA-21.50; Composite RotorTM,
Mountain View, CA) for 1.5 h.
Step 2: Anion Exchange Chromatography--
Cell-free extract
(0.84 g of protein) was applied to a column containing DEAE 650M TSK
TOYOPEARL® anion exchange resin (2.5 × 20 cm, 41.7-ml bed
volume; equilibrated with buffer A; Tosohaas, Montgomeryville, PA).
Twenty mg of protein was applied per ml of resin. The column was
developed at a flow rate of 60 ml h 1. After the sample
was applied, the column was washed with 170 ml of the buffer A,
followed by a 65-ml wash with buffer A containing 1 M NaCl.
Purification of the Fpr protein was monitored by SDS-PAGE.
Step 3: Dye Ligand Chromatography--
Fractions from the
previous step containing Fpr (254 mg of total protein) were applied to
a Reactive Red 120 column (2.5 × 20 cm, 76-ml bed volume; Sigma)
equilibrated with buffer A. Approximately 4 mg of protein was loaded
per ml of resin. The column was developed at a flow rate of 79 ml
h 1. After washing the column with 120 ml of buffer A,
bound proteins were eluted with a 310-ml linear gradient of NaCl
(0-1.0 M) in buffer A. Following the gradient, the column
was washed with 240 ml of buffer A containing 1.3 M NaCl to
elute tightly bound proteins. Fractions containing Fpr protein, as
judged by SDS-PAGE and UV-visible spectrum of the enzyme-bound flavin,
were pooled and concentrated using a Centriprep 10TM
concentrator (Millipore, Bedford, MA).
Step 4: Anion Exchange FPLC--
Purified Fpr protein was
applied to a Resource Q FPLC column (Amersha Pharmacia Biotech)
equilibrated with buffer A at 41 mg/ml of resin. Proteins bound to this
resin were eluted with a linear gradient of NaCl (0-1.0 M)
in buffer A. After this purification step, the Fpr protein was assessed
by SDS-PAGE to be 98% homogeneous. Eighteen mg of homogeneous Fpr
protein was obtained from the starting 20 g of cell material.
Purification of E. coli FldA
Step 1: Overproduction of FldA Protein and Generation of
Cell-free Extracts--
The flavodoxin protein was overproduced from
four 2-liter cultures of E. coli strain DH1/pDHO2 (R. G. Matthews, University of Michigan) grown on LB broth containing 100 µg/ml of ampicillin. The cells were grown at 37 °C to an
A650 of about 0.7. Isopropyl- -D-thiogalactoside was added to a final
concentration of 400 µM, and the incubation was continued
overnight. After incubation, the cells were harvested by centrifugation
at 10,000 × g for 10 min using a Sorvall GSA rotor
(DuPont), the cells (~25 g) were resuspended in 150 ml of 50 mM Tris-Cl buffer, pH 7.5, at 4 °C containing 16 µg of
phenylmethanesulfonyl fluoride/ml of extract. The cells were broken by
sonication using a sonic dismembrator for 7.5 min (large tip, setting
of 6, 50% duty). The cell-free extracts were generated by
centrifugation at 40,000 × g for 1.5 h using a
KOMP Spin rotor.
Step 2: Anion Exchange Chromatography on
DEAE-650M--
Cell-free extract (~1.5 g of protein) was applied to
a column containing DEAE 650M resin (2.5 × 20 cm, 70-ml bed
volume) equilibrated with buffer A. Approximately 22 mg of protein was
applied per ml of resin. The column was washed with 70 ml of loading
buffer followed by 140 ml of 100 mM sodium acetate buffer,
pH 5.0. Bound proteins were eluted with a linear gradient 100-500
mM NaCl in 100 mM sodium acetate buffer, pH
5.0. The pH of the fractions containing the FldA protein was brought up
to 7.0 with 2 M Tris-Cl buffer, pH 8.0, at 4 °C.
Fractions containing the FldA protein were pooled and dialyzed against
buffer A.
Step 3: Anion Exchange FPLC--
Fractions containing dialyzed
FldA protein (~315 mg of total protein) were applied to a POROS HQ
(PerSeptive Biosystems, Framingham, MA) anion exchange FPLC column
(1.0 × 10 cm, 7-ml bed volume) equilibrated with buffer A. Forty-five mg of protein was applied per ml of resin. The column was
washed with 14 ml of buffer A followed by a linear gradient of 0-1.5
M NaCl in buffer A. Fractions containing FldA were pooled,
dialyzed against buffer A, and stored at 90 °C in buffer A + 20%
(v/v) glycerol. After this purification step, the FldA protein was
assessed to be >95% homogeneous by SDS-PAGE. A total of 85 mg of FldA
was obtained from 25 g of starting material.
Purification of the CobA Enzyme of S. enterica
Purification of the CobA enzyme was performed as described in
Bauer et al. (14) without modifications.
Purification of the NAD(P)H:Flavin oxidoreductase (Fre)
Enzyme
Hexahistidine-tagged Fre enzyme (H6Fre) was purified
to homogeneity as described (20).
Protein Techniques
Total protein concentration was determined by the Bradford
method using the Bio-Rad protein reagent (26). Protein analysis was
performed by SDS-PAGE (27) stained with Coomassie Blue (28). The
concentration of the Fpr and FldA proteins was determined using the
reported extinction coefficients for the protein-bound flavins
(29).
In Vitro Activity Assays
Corrinoid Adenosylation Assays
Potassium borohydride-dependent CobA assays were
performed as described (13). The assay that demanded enzymic reduction of cob(III)alamin to cob(I)alamin was a modification of the corrinoid adenosylation assay previously reported (13). Conversion of (HOCbl) to
AdoCbl was monitored spectrophotometrically using a PerkinElmer Lambda
6 Spectrophotometer equipped with a temperature-regulated cuvette
holder. The assay mixtures (final volume, 1 ml) contained HOCbl (50 nmol), NADPH (500 nmol), ATP (400 nmol), MnCl2 or
MgCl2 (800 nmol), FMN (50 nmol), Tris-Cl buffer, pH 8.0, at
37 °C (200 µmol) homogeneous NAD(P)H:FMN oxidoreductase (Fre)
enzyme (50 units, where 1 unit of flavin reductase activity was defined
as the amount of enzyme required to reduce 1 nmol of FMN
( 450 = 12,200 M 1
cm 1)/min) (20), and Fpr, FldA, and CobA proteins at
various concentrations. Diacyanocob(III)inamide (CN)2Cbi)
alone and (CN)2Cbi) with hydroxocob(III)inamide were
used at a concentration of 20 µM when used as
corrinoid substrates in place of HOCbl. The reaction mixtures were
incubated at 37 °C in the spectrophotometer. In subsequent assays,
the Fpr protein was used to reduce cob(III)alamin to cob(II)alamin, and
thus FMN and Fre were omitted from these assays.
AdoCbl formation was monitored by the increase in the absorbance of the
solution at 525 nm as a function of time. The amount of product
generated was calculated using the difference in molar extinction
coefficient between the substrate, cob(II)alamin, and the product,
AdoCbl, at 525 nm ( 525 = 4.8 × 10 3
M 1 cm 1). One unit of CobA
activity was defined as the amount of enzyme required to generate 1 nmol of AdoCbl/min (13).
Cytochrome c Reductase Assays
Activity of the Fpr protein was monitored using the cytochrome
c reductase assay as reported by Fujii et al.
(22, 23), except the assays were performed under anoxic conditions to
mimic the conditions used in the corrinoid adenosylation assays.
1,2-Propanediol Dehydratase Assays
In vitro assays for AdoCbl-dependent
1,2-propanediol dehydratase (a gift from Perry A. Frey) were performed
as described (30). The conversion of 1,2-propanediol to propionaldehyde
was measured by derivatization of the product with
3-methyl-2-benzothiazoline hydrazone yielding an azine product that can
be measured spectrophotometrically at 305 nm ( 305 = 13,300 M 1 cm 1). This assay was
used as a measure of coenzymic activity of enzymically generated
AdoCbl. One unit of 1,2-propanediol dehydratase is defined as the
amount of enzyme required to generate 1 µmol of propionaldehyde/min under the conditions of the assay.
Synthesis of Aquocobinamide (H2OCbi)
H2OCbi was synthesized in vitro from
(CN)2Cbi. First, AdoCbi was synthesized from
(CN)2Cbi using the potassium
borohydride-dependent corrinoid adenosylation assays. The
assays were performed as described (13), except (CN)2Cbi
(50 µM) was substituted for HOCbl. After substrate
conversion was complete, the reaction mixture was exposed to air and
filtered through a 45-µm (25-mm diameter) syringe filter (Nalgene,
Rochester, NY). The corrinoid product was isolated using a
C18 SepPak cartridge (Waters, Milford, MA) and dried using
a SpeedVac concentrator (Savant Instruments, Farmingdale, NY).
Concentrated AdoCbi was resuspended in 400 µl of water and photolyzed
aerobically using a tungsten/halogen lamp placed ~20 cm away from the
tube containing the sample. Using this procedure, AdoCbi was converted by heterolysis to H2OCbi. The sample was passed through a
C18 cartridge as described above. H2OCbi was
converted to (CN)2Cbi by photolysis in 0.1 M
KCN, pH 10.0, using a tungsten/halogen lamp and quantitated using the
molar extinction coefficient for (CN)2Cbi at 367 nm
( 367 = 30,800 M 1
cm 1) (31).
Reverse Phase HPLC (RP-HPLC) Analysis of Reaction Products
The products of the corrinoid adenosylation assays were isolated
and analyzed by RP-HPLC on a Prodigy ODS (8) column (Phenomenex, Torrance, CA) attached to an HPLC system as described (32). A
photodiode array detector (Waters) was used to identify corrinoids by
their UV-visible spectra. Authentic HOCbl and AdoCbl were used as
standards. The isolated corrinoids were desalted using a
C18 SepPak cartridge and dried in a SpeedVac concentrator.
Mass Spectrometry
Mass spectrometry of purified reaction products was performed at
the Mass Spectrometry Facility at the University of Wisconsin-Madison Biotechnology Center.
In Vivo Assessment of Adenosylcorrinoid Synthesis
In vitro synthesis of adenosylcorrinoids was assessed
in vivo by using strain JE1096 (metE205 ara-9
cobA343::MudJ) as an indicator strain in a biological
activity assays. The cells of the indicator strain grown overnight in 2 ml of nutrient broth were concentrated by centrifugation and washed
with 14.5 mM sterile saline; 0.1 ml of the cell suspension
(~108 cells) was added to 3 ml of molten soft agar (0.7%
w/v) and used to overlay a plate of Vogel-Bonner minimal medium (33)
containing glucose (11 mM) as carbon and energy source. The
corrinoid standards AdoCbi, (CN)2Cbi, and Cbl (~50 pmol
each) and reaction products were spotted onto the overlay and incubated
overnight at 37 °C.
 |
RESULTS |
Homogeneous Fpr, FldA, and CobA Proteins Are Sufficient for in
Vitro Conversion of Cob(III)alamin to
AdoCbl--
NADPH-dependent synthesis of AdoCbl was
conducted when cell-free extracts of strains overexpressing Fpr
(ferredoxin(flavodoxin):NADP+ oxidoreductase) and
FldA (flavodoxin A) proteins were added to corrinoid adenosylation
assay mixtures in place of potassium borohydride (data not shown).
Control experiments in which either cell-free extract was omitted
failed to yield a product, suggesting a requirement for both Fpr and
FldA proteins. These proteins were isolated to homogeneity to further
investigate their involvement the corrinoid adenosylation reaction.
Homogeneous Fpr protein (Fig. 2,
lane A) used in this work had a cytochrome c
reductase specific activity of 0.36 µmol cyt c
min 1 mg 1 of protein, and a specific content
of 42 nmol of Fpr/mg of protein. Initially, the cob(II)alamin substrate
was generated using NAD(P)H:flavin oxidoreductase H6Fre
enzyme, NADH, and FMN (20). Once the Fpr protein was
isolated, it was used in lieu of H6Fre to reduce HOCbl to cob(II)alamin. Elimination of the H6Fre protein
simplified the reaction conditions.

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 2.
Denaturing polyacrylamide gel electrophoretic
analysis of purified of proteins required for in vitro
corrinoid adenosylation. Lane A, homogeneous Fpr
enzyme. Lane B, homogeneous FldA protein. Lane C,
homogeneous CobA enzyme. Molecular mass standards are shown on the
right (in kDa).
|
|
The FldA protein was purified to >95% homogeneity (Fig. 2, lane
B). Approximately 85 mg of protein was obtained from 25 g of
wet mass. The specific flavoprotein content for this preparation was 22 nmol of FldA/mg of protein. FldA protein was reduced by Fpr, and
reduced FldA was coupled to CobA enzyme in the corrinoid adenosylation
assays. This system converted cob(III)alamin or cob(III)inamide to
their corresponding adenosylated derivatives. NADPH was required, but
unlike other systems, no further addition of FAD or FMN to the reaction
mixture was necessary (7, 8, 19, 20).
When Fpr and FldA proteins were coupled to the CobA enzyme, AdoCbl
synthesis was observed (Fig.
3A). The characteristic
changes associated with conversion of cob(II)alamin to the final
product, AdoCbl (Fig. 3B), were not observed when either one
of the enzymes was omitted from the reaction mixture. These spectral
changes were in good agreement with those observed for this conversion in other systems (7). The identity of the products of these reactions
was further confirmed by the analyses shown below.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 3.
A, in vitro conversion of
cob(III)alamin to AdoCbl by homogeneous Fpr, FldA, and CobA proteins.
Coupled corrinoid adenosylation assays contained: 100 µmol of NADPH,
50 nmol of HOCbl, 400 nmol of ATP, 800 nmol of MnCl2, 50 nmol of FMN, 50 units of purified H6Fre enzyme, 4.7 nmol of
purified Fpr enzyme, 3.2 nmol of purified FldA protein, and 1.4 nmol of
purified CobA enzyme in Tris-Cl buffer, pH 8.0, at 37 °C (200 µmol). Spectrum 1, AdoCbl product of the complete reaction
mixture; spectrum 2, cob(II)alamin product of a reaction in
which the FldA protein was omitted; spectrum 3,
cob(II)alamin product of a reaction in which the Fpr enzyme was
omitted; spectrum 4, cob(II)alamin product of a reaction in
which the CobA enzyme was omitted. B, spectral changes
associated with the conversion of cob(III)alamin to AdoCbl. Protein
concentrations were as follows: 0.7 nmol of Fpr; 2.1 nmol of FldA, and
0.9 nmol of CobA. Spectrum 1, UV-visible spectrum of the
solution at the start of the reaction; spectrum 2,
UV-visible spectrum of the solution 10 min after the reaction was
started; spectrum 3, UV-visible spectrum of the solution 20 min after the reaction was started; spectrum 4, UV-visible
spectrum of the solution 30 min after the reaction was started;
spectrum 5, UV-visible spectrum of the solution one hr after
the reaction was started. C, time course for the enzymic
conversion of cob(III)alamin to AdoCbl. Protein concentrations were as
follows: 0.7 nmol of Fpr, 2.1 nmol of FldA, and 0.5 nmol of CobA. The
reaction conditions were as described under "Experimental
Procedures."
|
|
Linearity of the Reaction--
The rate of product formation was
linear when the concentration of the FldA protein in the reaction
mixture ranged between 0.5 and 2.0 µM (0.2-0.4 nmol of
AdoCbl min 1). The rate of the reaction was also linear
when CobA enzyme was present in the reaction mixture in the range of
0.5-1.5 µM (0.2-0.5 nmol AdoCbl min 1).
These results indicated a 1:1 CobA:FldA stoichiometry.
Identification of the Product of the Reaction--
The product of
the corrinoid adenosylation reaction was isolated by RP-HPLC. When
HOCbl was used as substrate, the elution time (Fig.
4A, 21.9 min) and UV-visible
spectrum of the isolated product was identical to an AdoCbl standard
isolated by the same procedure (Fig. 4B). When the reducing
system (Fpr, FldA) was omitted from the reaction mixture, a product
with an elution time (18.7 min) and UV-visible spectrum identical to
that of a HOCbl standard was obtained (data not shown).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 4.
Isolation of the reaction product by
RP-HPLC. A, elution profile of the reaction product of
the coupled corrinoid adenosylation assays as isolated by RP-HPLC. The
product of the reaction had an elution time of 21.9 min. Commercially
available AdoCbl subjected to the same procedure eluted at 22.0 min
(data not shown). B, UV-visible spectrum of the isolated
corrinoid. Inset, UV-visible spectrum of authentic
AdoCbl.
|
|
The isolated product was analyzed by electrospray ionization (ESI) mass
spectrometry (Fig. 5). The positive-ion
ESI mass spectrum showed signals with m/z values
of 829.2 and 1582.2, which corresponded to masses of KAdoCbl (z = +2) and AdoCbl (z = +1), respectively. The negative-ion ESI mass
spectrum of the product showed a parent peak with an
m/z value 1367.8 (z = +1), in agreement with
the molecular mass for NaHOCbl and suggesting that the Ado group was removed during analysis. This was confirmed by the negative-ion ESI
mass spectrum of authentic AdoCbl isolated by HPLC (Fig.
5B). The positive ion ESI mass spectrum of authentic AdoCbl
showed a signal at m/z = 829.4, consistent
with the molecular masses of KAdoCbl (z = +2).

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 5.
Mass spectrometry analysis of the product of
the coupled corrinoid adenosylation assay. A, positive
and negative ion ESI mass spectra of the reaction product isolated by
RP-HPLC. B, positive and negative ion ESI mass spectra of
authentic AdoCbl isolated by RP-HPLC.
|
|
AdoCbl Generated by the Enzymic System Has Coenzymic
Activity--
Approximately 0.1 nmol of enzymically generated AdoCbl
was added to 1,2-propanediol dehydratase reaction mixtures. The amount of propionaldehyde generated from the dehydration of 1,2-propanediol during the reaction was identical to that of a reaction performed using
0.1 nmol of commercially available AdoCbl (specific activity, 0.02 unit/mg), indicating that enzymically generated AdoCbl was biologically active.
In Vitro Reduction and Adenosylation of Cobinamide
Derivatives--
Corrinoid adenosylation assays were performed using
either (CN)2Cbi or H2OCbi as substrate. When
(CN)2Cbi was used, the rate conversion of this substrate to
AdoCbi was slow, as judged by the changes in the UV-visible spectrum
associated with this conversion (Fig.
6A). High concentrations of
the flavoprotein system and of the CobA enzyme were required to drive
the reaction to near completion (Fig. 6A, spectrum
5). The UV-visible spectrum of the product obtained under these
conditions was in good agreement with that reported for AdoCbi (13,
34). The absorbance peak at 579 nm (Fig. 6A, spectrum
5) was indicative of unreacted substrate. These results indicated
that the cyanide ligands were removed upon reduction of the cobalt ion
to generate the four-coordinate cob(I)inamide substrate for CobA. When
H2OCbi was used as substrate (Fig. 6B), the
apparent rate for adenosylation was approximately twice as fast,
indicating that removal of the cyanide ligands was the rate-limiting
step when (CN)2Cbi was used as substrate.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 6.
In vitro reduction and
adenosylation of cobinamide. A, spectral changes
associated with the enzymic conversion of (CN)2Cbi to
AdoCbi. Protein concentrations were as follows: 0.7 nmol of Fpr, 2.1 nmol of FldA, and 0.9 nmol of CobA. Spectrum 1, UV-visible
spectrum of the starting substrate; spectrum 2, UV-visible
spectrum of the solution upon addition of NADPH, Fpr, FldA, ATP, and
CobA; spectrum 3, UV-visible spectrum of the solution 15 min
after the reaction was started; spectrum 4, UV-visible
spectrum of the solution 2 h after the reaction was started;
spectrum 5, UV-visible spectrum of the product
obtained after 12 h of incubation. Protein concentrations required
to obtain this product were: 3.0 nmol of Fpr, 2.1 nmol of FldA, and 1.4 nmol of CobA. The remaining peak at 579 nm indicated incomplete
conversion of the substrate under the conditions of the assay.
B, spectral changes associated with the enzymic conversion
of hydroxocob(III)inamide to AdoCbi. Protein concentrations were as
follows: 0.7 nmol of Fpr, 2.1 nmol of FldA, and 0.9 nmol of CobA.
Spectrum 1, UV-visible spectrum of the starting substrate
HOCbl; spectrum 2, UV-visible spectrum of the solution upon
addition of NADPH, Fpr, FldA, and CobA. spectrum 3,
UV-visible spectrum of the solution upon addition of ATP and CobA;
spectrum 4, UV-visible spectrum of the solution 30 min after
the reaction was started; spectrum 5, UV-visible spectrum of
the solution 1 h after the reaction was started.
|
|
To confirm that the product of the in vitro reaction was
AdoCbi, strain JE1096 was used to test for biological activity
(Fig. 7). Strain JE1096 is a methionine
auxotroph correctable by AdoCbi or Cbl (11). A strong growth response
was observed when the product of the reaction was provided to the
indicator strain. Growth of the cobA mutant strain was also
observed with AdoCbi generated in
KBH4-dependent adenosylation assays (Fig. 7).
As expected, a growth response was not observed when
(CN)2Cbi was provided in the assay. These results confirmed
that the product was AdoCbi.

View larger version (60K):
[in this window]
[in a new window]
|
Fig. 7.
In vivo assessment of
adenosylcorrinoid synthesis. A biological activity assay was used
to detect AdoCbi in the reaction mixture. The product of the reaction
was provided to strain JE1096 (met205 ara-9
cobA343::MudJ). This strain is a methionine auxotroph
unless AdoCbi or Cbl is provided in the medium. A growth response was
observed when the product of the reaction is provided to the indicator
strain. Authentic cyanocobalamin, (CN)2Cbi, and AdoCbi were
provided as controls for the growth response.
|
|
 |
DISCUSSION |
The data reported herein show that the reducing system comprised
of the Fpr and FldA proteins is sufficient for the generation of the
co(I)rrinoid substrate of the ATP:co(I)rrinoid adenosyltransferase CobA
enzyme of S. enterica. To the best of our knowledge, this is
the first report of a reducing system that can be coupled to the CobA
enzyme for the generation of adenosylated corrinoids.
The involvement of the FldA protein in the corrinoid
adenosylation reaction is consistent with the ability of
this protein to work at low redox potentials as a one-electron
carrier (21, 22, 35, 36) and with its involvement in the reduction
of cob(II)alamin to cob(I)alamin on the
Cbl-dependent methionine synthase MetH enzyme (21-24, 37).
The validity of the conclusions drawn from this work is not affected by
the use of E. coli FldA and Fpr proteins given the high
degree of identity shared by the proteins in these bacteria (Fig.
8), strongly suggesting that these
proteins perform equivalent functions in these procaryotes. Thus it is
reasonable to think that reduced FldA might represent a natural
reducing system for corrinoid adenosylation in enterobacteria (e.g. E. coli and S. enterica).

View larger version (59K):
[in this window]
[in a new window]
|
Fig. 8.
Amino acid sequence alignments of the
E. coli and S. enterica Fpr and FldA
proteins. Sequence alignments were performed using the CLUSTAL W
program (43). Sequences were also analyzed using the National Center
for Biotechnology Information BLAST 2.0 program (44). Preliminary
sequence information for S. enterica serovar
Typhimurium LT2 was obtained from the Genome Sequencing Center
(Washington University, St. Louis, MO) data base (Genome Sequencing
Center, http://genome.wustl.edu/gsc/Blast/client.pl).
Identical amino acid residues are marked by asterisks.
Differences between sequences are highlighted in gray.
A, E. coli Fpr versus S. enterica Fpr. B, E. coli FldA
versus S. enterica FldA.
|
|
The Site of Corrinoid Reduction--
The very low redox potential
of the free cob(II)alamin/cob(I)alamin couple (E°' = 610
mV) (38) and the extreme reactivity of the cob(I)alamin nucleophile
(39) strongly suggest that reduction of cob(II)alamin occurs on the
CobA enzyme. It is unlikely that cob(II)alamin reduction occurs in
solution because the midpoint redox potentials for the semiquinone and
hydroquinone forms of free FldA ( 260 and 440 mV, respectively) (21)
are too high to account for the generation of the cob(I)alamin
nucleophile via a second order reaction. The redox potential for this
reaction is expected to be close to the redox potential for free
cob(II)alamin and thus considerably lower than that of the
cob(II)alamin form of free methionine synthase (21, 38). In addition,
the lower axial ligand of HOCbl has been shown to be coordinated to the cobalt in the CobA crystal structure (Fig. 8) (14). Generation of the
cob(I)alamin substrate for CobA ligand would require lower ligand
dissociation from the cobalt ion. This reaction is known to raise the
redox potential of the cob(II)alamin/cob(I)alamin couple (21, 40).
Interactions between FldA and CobA coupled to product formation are
therefore expected to raise the redox potential to facilitate the
reaction. The documented mechanisms for MetH reactivation as well as
the FldA-dependent anaerobic ribonucleotide reductase
activation reaction support this hypothesis (24, 41). Interactions
between the FldA and CobA proteins are an attractive possibility, when
one also considers the location of the corrinoid-binding site in CobA
(14). The ternary complex structure between HOCbl, ATP, and CobA show
that the corrinoid binding site is located near the surface of the
enzyme (Fig. 9). The interactions between
FldA and CobA and/or the reduction of the corrinoid may be responsible
for the hypothesized conformational changes CobA must undergo to bring
the target C5' of the ribose closer to the cobalt atom for the
nucleophilic attack to occur (14). Work addressing these important
aspects of the reaction is currently being performed.

View larger version (56K):
[in this window]
[in a new window]
|
Fig. 9.
Stereo view of the ternary complex between
CobA, HOCbl and ATP (14). Shown is a ribbon representation of the
complex between CobA and its substrates. Only one HOCbl molecule is
observed in this representation, bound at the surface of subunit A. The
N-terminal -helix from subunit B is shown interacting with the
nucleotide loop of the HOCbl molecule bound to subunit A. The
lower ligand, 5,6-dimethylbenzimidazole, is shown coordinated to the
cobalt ion of the corrin ring.
|
|
Is FldA Involved in Corrinoid Adenosylation in Vivo?--
The
answer to this question is complicated by the fact that mutations in
the fldA gene have been found to be lethal under aerobic and
anaerobic growth conditions, suggesting that FldA is an essential
function (42). Thus a genetic approach to this question is not
possible. Because of this, we are not able to determine whether
FldA is one redundant function in co(II)rrinoid reduction for
adenosylation or whether it is solely responsible for this process. If
FldA were an in vivo corrinoid reductase involved in
corrinoid adenosylation, it would explain why cob(II)alamin reductase
mutants have not been isolated. The chemistry of the reaction together
with the data presented herein suggest that a true in vivo
reductant for this process must be a low redox one-electron carrier and
that, if the proposed interactions with the CobA enzyme are required,
at least some specificity would be expected.
The Corrinoid Adenosylation Pathway in S. enterica--
The
schematic of the corrinoid adenosylation pathway shown in Fig.
10 incorporates the findings reported
in this paper. In this model, reduction of co(III)rrinoid to
co(II)rrinoid is shown catalyzed by endogenous dihydroflavin
nucleotides or by the Fpr enzyme. The Fpr enzyme uses NADPH to reduce
FldA, which in turn transfers an electron to Co(II) to yield Co(I).
Electrons for co(II)rrinoid reduction are proposed to be transferred by
reduced FldA when the corrinoid is bound to the CobA enzyme. The
nucleophilic attack by Co(I) on the C5' of the ribosyl moiety of ATP
results in the release of inorganic
tripolyphosphate.2 Putative
interactions between the FldA and CobA proteins are currently under
investigation.

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 10.
The corrinoid adenosylation pathway in
S. enterica. Electrons for reduction of
co(III)rrinoids to co(I)rrinoids are donated by NADPH through flavins,
Fpr, or FldA. The Fpr enzyme reduces FldA to the semiquinone form
for generation of the co(I)rrinoid substrate of CobA.
e , electron; Fpr·FAD, oxidized
form of Fpr; Fpr·FADH2, hydroquinone form of Fpr;
FldA·FMN, oxidized form of FldA;
FldA·FMNH·, semiquinone form of flavodoxin;
PPPi, tripolyphosphate.
|
|
 |
ACKNOWLEDGEMENTS |
We thank R. G. Matthews (University of
Michigan) and E. Haggård-Ljungquist (Karolinska Institutet, Stockholm,
Sweeden) for strains and plasmids. We thank P. A. Frey (University
of Wisconsin-Madison, Biochemistry Department) for the gift of
1,2-propanediol dehydratase. We thank I. Rayment (University of
Wisconsin-Madison, Biochemistry Department) for assistance in
generating the stereo-view of the CobA enzyme. We thank R. Schwartz
(University of Wisconsin-Madison, Bacteriology Department) for
technical assistance. We thank the Genome Sequencing Center, Washington
University, St. Louis, MO (http://genome.wustl.edu/gsc/Search/policy.shtml) for allowing access
to S. enterica DNA sequence data prior to publication.
 |
FOOTNOTES |
*
This work was supported in part by National Institutes of
Health Grant GM40313 and by a DuPont Aid-To-Education grant (to J. C. E.-S.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Use of this system is regulated by patent P00259US.
Recipient of a Minority Access to Research Careers (MARC)
predoctoral fellowship GM17528.
§
To whom correspondence should be addressed: Dept. of Bacteriology,
1550 Linden Dr., Madison, WI 53706-1567. Tel.: 608-262-7379; Fax: 608-262-9865; E-mail: jcescala@facstaff.wisc.edu.
Published, JBC Papers in Press, June 14, 2001, DOI 10.1074/jbc.M102510200
2
M. V. Fonseca and J.C. Escalante-Semerena,
unpublished results.
 |
ABBREVIATIONS |
The abbreviations used are:
AdoCbl, adenosylcobalamin;
ATP, adenosine triphosphate;
CNCbl, cyanocobalamin;
RP-HPLC, reverse phase high performance, liquid chromatography;
Cbl, cobalamin;
(CN)2Cbi, diacyanocob(III)inamide;
(H2OCbi), aquocob(III)inamide;
FMN, flavin mononucleotide;
NADPH, nicotinamide adenine dinucleotide phosphate, reduced form;
Fre, NAD(P)H:flavin oxidoreductase (EC 1.6.8.1);
H6Fre, hexahistidine-tagged Fre;
Fpr, ferredoxin
(flavodoxin):NADP+ reductase (EC 1.18.1.2);
FldA, flavodoxin;
CobA, ATP:co(I)rrinoid adenosyltransferase (EC 2.5.1.17);
MetH, E. coli
N10-methyltetrahydrofolate:homocysteine
methyltransferase (methionine synthase, EC 2.1.1.13);
1, 2-propanediol
dehydratase, DL-1,2-propanediol hydro-lyase. (EC 4.2.1.28);
PAGE, polyacrylamide gel electrophoresis;
FPLC, fast protein liquid
chromatography;
HOCbl, hydroxocob(III)alamin;
ESI, electrospray
ionization.
 |
REFERENCES |
| 1.
|
Battersby, A. R.
(1994)
Science
264,
1551-1557
|
| 2.
|
Rondon, M. R.,
Trzebiatowski, J. R.,
and Escalante-Semerena, J. C.
(1997)
Prog. Nucleic Acids Res. Mol. Biol.
56,
347-384
|
| 3.
|
Blanche, F.,
Cameron, B.,
Crouzet, J.,
Debussche, L.,
Thibaut, D.,
Vuilhorgne, M.,
Leeper, F. J.,
and Battersby, A. R.
(1995)
Angew. Chem. Int. Ed. Engl.
34,
383-411
|
| 4.
|
Lawrence, J.,
and Roth, J. R.
(1995)
J. Bacteriol.
177,
6371-6380
|
| 5.
|
Santander, P. J.,
Roessner, C. A.,
Stolowich, N.,
Holderman, M. T.,
and Scott, A. I.
(1997)
Chem. Biol.
4,
659-666
|
| 6.
|
Raux, E.,
Thermes, C.,
Heathcote, P.,
Rambach, A.,
and Warren, M. J.
(1997)
J. Bacteriol.
179,
3202-3212
|
| 7.
|
Walker, G. A.,
Murphy, S.,
and Huennekens, F. M.
(1969)
Arch. Biochem. Biophys.
134,
95-102
|
| 8.
|
Brady, R. O.,
Castanera, E. G.,
and Barker, H. A.
(1962)
J. Biol. Chem.
223,
2325-2332
|
| 9.
|
Vitols, E.,
Walker, G. A.,
and Huennekens, F. M.
(1966)
J. Biol. Chem.
241,
1455-1461
|
| 10.
|
Debussche, L.,
Couder, M.,
Thibaut, D.,
Cameron, B.,
Crouzet, J.,
and Blanche, F.
(1991)
J. Bacteriol.
173,
6300-6302
|
| 11.
|
Escalante-Semerena, J. C.,
Suh, S.-J.,
and Roth, J. R.
(1990)
J. Bacteriol.
172,
273-280
|
| 12.
|
Suh, S.-J.,
and Escalante-Semerena, J. C.
(1993)
Gene (Amst.)
129,
93-97
|
| 13.
|
Suh, S.-J.,
and Escalante-Semerena, J. C.
(1995)
J. Bacteriol.
177,
921-925
|
| 14.
|
Bauer, C. B.,
Fonseca, M. V.,
Holden, H. M.,
Thoden, J. B.,
Thompson, T. B.,
Escalante-Semerena, J. C.,
and Rayment, I.
(2001)
Biochemistry
40,
361-374
|
| 15.
|
Drennan, C. L.,
Huang, S.,
Drummond, J. T.,
Matthews, R. G.,
and Ludwig, M. L.
(1994)
Science
266,
1660-1674
|
| 16.
|
Mancia, F.,
Keep, N. H.,
Nakagawa, A.,
Leadlay, P. F.,
McSweeney, S.,
Rasmussen, B.,
Bösecke, P.,
Diat, O.,
and Evans, P. R.
(1996)
Structure
4,
339-350
|
| 17.
|
Shibata, N.,
Masuda, J.,
Tobimatsu, T.,
Toraya, T.,
Suto, K.,
Morimoto, Y.,
and Yasuoka, N.
(1999)
Structure Fold Des.
7,
997-1008
|
| 18.
|
Reitzer, R.,
Gruber, K.,
Jogl, G.,
Wagner, U. G.,
Bothe, H.,
Buckel, W.,
and Kratky, C.
(1999)
Structure Fold Des.
7,
891-902
|
| 19.
|
Blanche, F.,
Maton, L.,
Debussche, L.,
and Thibaut, D.
(1992)
J. Bacteriol.
174,
7452-7454
|
| 20.
|
Fonseca, M. V.,
and Escalante-Semerena, J. C.
(2000)
J. Bacteriol.
182,
4304-4309
|
| 21.
|
Hoover, D. M.,
Jarrett, J. T.,
Sands, R. H.,
Dunham, W. R.,
Ludwig, M. L.,
and Matthews, R. G.
(1997)
Biochemistry
36,
127-138
|
| 22.
|
Fujii, K.,
and Huennekens, F. M.
(1974)
J. Biol. Chem.
249,
6745-6753
|
| 23.
|
Fujii, K.,
Galivan, J. H.,
and Huennekens, F. M.
(1977)
Arch. Biochem. Biophys.
178,
662-670
|
| 24.
|
Jarrett, J. T.,
Hoover, D. M.,
Ludwig, M. L.,
and Matthews, R. G.
(1998)
Biochemistry
37,
12649-12658
|
| 25.
|
Hall, D. A.,
Jordan-Starck, T. C.,
Loo, R. O.,
Ludwig, M. L.,
and Matthews, R. G.
(2000)
Biochemistry
39,
10711-10719
|
| 26.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-255
|
| 27.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685
|
| 28.
|
Sasse, J.
(1991)
in
Current Protocols in Molecular Biology
(Ausubel, F. A.
, Brent, R.
, Kingston, R. E.
, Moore, D. D.
, Seidman, J. G.
, Smith, J. A.
, and Struhl, K., eds), Vol. 1
, pp. 10.6.1-10.6.8, Wiley Interscience, New York
|
| 29.
|
Hoover, D. M.,
and Ludwig, M. L.
(1997)
Protein Sci
6,
2525-2537
|
| 30.
|
Toraya, T.,
Ushio, K.,
Fukui, S.,
and Hogenkamp, P. C.
(1977)
J. Biol. Chem.
252,
963-970
|
| 31.
|
Hogenkamp, H. P. C.
(1975)
in
Cobalamin: Biochemistry and Pathophysiology
(Babior, B. M., ed)
, pp. 21-74, John Wiley & Sons, New York
|
| 32.
|
O'Toole, G. A.,
Rondon, M. R.,
and Escalante-Semerena, J. C.
(1993)
J. Bacteriol.
175,
3317-3326
|
| 33.
|
Vogel, H. J.,
and Bonner, D. M.
(1956)
J. Biol. Chem.
218,
97-106
|
| 34.
|
Thomas, M. G.,
and Escalante-Semerena, J. C.
(2000)
J. Bacteriol.
182,
4227-4233
|
| 35.
|
Vetter, H., Jr.,
and Knappe, J.
(1971)
Hoppe-Seyler's Z. Physiol. Chem.
352,
433-446
|
| 36.
|
Vervoort, J.,
Muller, F.,
LeGall, J.,
Bacher, A.,
and Sedlmaier, H.
(1985)
Eur. J. Biochem.
151,
49-57
|
| 37.
|
Jarrett, J. T.,
Huang, S.,
and Matthews, R. G.
(1998)
Biochemistry
37,
5372-5382
|
| 38.
|
Banerjee, R. V.,
Harder, S. R.,
Ragsdale, S. W.,
and Matthews, R. G.
(1990)
Biochemistry
29,
1129-1135
|
| 39.
|
Schrauzer, G. N.,
Deutsch, E.,
and Windgassen, R. J.
(1968)
J. Am. Chem. Soc.
90,
2441-2442
|
| 40.
|
Lexa, D.,
and Saveant, J.-M.
(1983)
Acc. Chem. Res.
16,
235-243
|
| 41.
|
Mulliez, E.,
Padovani, D.,
Atta, M.,
Alcouffe, C.,
and Fontecave, M.
(2001)
Biochemistry
40,
3730-3736
|
| 42.
|
Gaudu, P.,
and Weiss, B.
(2000)
J. Bacteriol.
182,
1788-1793
|
| 43.
|
Thompson, J. D.,
Higgins, D. G.,
and Gibson, T. J.
(1994)
Nucleic Acids Res.
22,
4673-4680
|
| 44.
|
Altschul, S. F.,
Madden, T. L.,
Schaffer, A. A.,
Zhang, J.,
Miller, W.,
and Lipmann, D. J.
(1997)
Nucleic Acids Res.
25,
3389-3402
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. D. Lawrence, E. Deery, K. J. McLean, A. W. Munro, R. W. Pickersgill, S. E. J. Rigby, and M. J. Warren
Identification, Characterization, and Structure/Function Analysis of a Corrin Reductase Involved in Adenosylcobalamin Biosynthesis
J. Biol. Chem.,
April 18, 2008;
283(16):
10813 - 10821.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Escalante-Semerena
Conversion of Cobinamide into Adenosylcobamide in Bacteria and Archaea
J. Bacteriol.,
July 1, 2007;
189(13):
4555 - 4560.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. St. Maurice, P. E. Mera, M. P. Taranto, F. Sesma, J. C. Escalante-Semerena, and I. Rayment
Structural Characterization of the Active Site of the PduO-Type ATP:Co(I)rrinoid Adenosyltransferase from Lactobacillus reuteri
J. Biol. Chem.,
January 26, 2007;
282(4):
2596 - 2605.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. R. Buan and J. C. Escalante-Semerena
Purification and Initial Biochemical Characterization of ATP:Cob(I)alamin Adenosyltransferase (EutT) Enzyme of Salmonella enterica
J. Biol. Chem.,
June 23, 2006;
281(25):
16971 - 16977.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. R. Buan, K. Rehfeld, and J. C. Escalante-Semerena
Studies of the CobA-Type ATP:Co(I)rrinoid Adenosyltransferase Enzyme of Methanosarcina mazei Strain Go1.
J. Bacteriol.,
May 1, 2006;
188(10):
3543 - 3550.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. R. Buan and J. C. Escalante-Semerena
Computer-assisted Docking of Flavodoxin with the ATP:Co(I)rrinoid Adenosyltransferase (CobA) Enzyme Reveals Residues Critical for Protein-Protein Interactions but Not for Catalysis
J. Biol. Chem.,
December 9, 2005;
280(49):
40948 - 40956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Sampson, C. L. V. Johnson, and T. A. Bobik
Biochemical evidence that the pduS gene encodes a bifunctional cobalamin reductase
Microbiology,
April 1, 2005;
151(4):
1169 - 1177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A. Leal, H. Olteanu, R. Banerjee, and T. A. Bobik
Human ATP:Cob(I)alamin Adenosyltransferase and Its Interaction with Methionine Synthase Reductase
J. Biol. Chem.,
November 12, 2004;
279(46):
47536 - 47542.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. R. Buan, S.-J. Suh, and J. C. Escalante-Semerena
The eutT Gene of Salmonella enterica Encodes an Oxygen-Labile, Metal-Containing ATP:Corrinoid Adenosyltransferase Enzyme
J. Bacteriol.,
September 1, 2004;
186(17):
5708 - 5714.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Saridakis, A. Yakunin, X. Xu, P. Anandakumar, M. Pennycooke, J. Gu, F. Cheung, J. M. Lew, R. Sanishvili, A. Joachimiak, et al.
The Structural Basis for Methylmalonic Aciduria: THE CRYSTAL STRUCTURE OF ARCHAEAL ATP:COBALAMIN ADENOSYLTRANSFERASE
J. Biol. Chem.,
May 28, 2004;
279(22):
23646 - 23653.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Woodson and J. C. Escalante-Semerena
CbiZ, an amidohydrolase enzyme required for salvaging the coenzyme B12 precursor cobinamide in archaea
PNAS,
March 9, 2004;
101(10):
3591 - 3596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Rodionov, A. G. Vitreschak, A. A. Mironov, and M. S. Gelfand
Comparative Genomics of the Vitamin B12 Metabolism and Regulation in Prokaryotes
J. Biol. Chem.,
October 17, 2003;
278(42):
41148 - 41159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Woodson, R. F. Peck, M. P. Krebs, and J. C. Escalante-Semerena
The cobY Gene of the Archaeon Halobacterium sp. Strain NRC-1 Is Required for De Novo Cobamide Synthesis
J. Bacteriol.,
January 1, 2003;
185(1):
311 - 316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Dobson, T. Wai, D. Leclerc, H. Kadir, M. Narang, J. P. Lerner-Ellis, T. J. Hudson, D. S. Rosenblatt, and R. A. Gravel
Identification of the gene responsible for the cblB complementation group of vitamin B12-dependent methylmalonic aciduria
Hum. Mol. Genet.,
December 15, 2002;
11(26):
3361 - 3369.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. V. Fonseca, N. R. Buan, A. R. Horswill, I. Rayment, and J. C. Escalante-Semerena
The ATP:Co(I)rrinoid Adenosyltransferase (CobA) Enzyme of Salmonella enterica Requires the 2'-OH Group of ATP for Function and Yields Inorganic Triphosphate as Its Reaction Byproduct
J. Biol. Chem.,
August 30, 2002;
277(36):
33127 - 33131.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|